Manfred P. Lutz

7.7k total citations · 2 hit papers
114 papers, 4.7k citations indexed

About

Manfred P. Lutz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Manfred P. Lutz has authored 114 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 37 papers in Surgery. Recurrent topics in Manfred P. Lutz's work include Colorectal Cancer Treatments and Studies (39 papers), Pancreatic and Hepatic Oncology Research (25 papers) and Gastric Cancer Management and Outcomes (23 papers). Manfred P. Lutz is often cited by papers focused on Colorectal Cancer Treatments and Studies (39 papers), Pancreatic and Hepatic Oncology Research (25 papers) and Gastric Cancer Management and Outcomes (23 papers). Manfred P. Lutz collaborates with scholars based in Germany, Belgium and France. Manfred P. Lutz's co-authors include Eric Van Cutsem, Bernard Nordlinger, Murielle Mauer, Wolf O. Bechstein, Roger Vogelmann, Guido Adler, Werner Scheithauer, G. Adler, Jana Prausová and Joan Maurel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Manfred P. Lutz

110 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

2008 726 citations Manfred P. Lutz et al. profile →
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

2010 507 citations Murielle Mauer, Wolf O. Bechstein et al. profile →

Peers

Countries citing papers authored by Manfred P. Lutz

Since Specialization

Citations

This map shows the geographic impact of Manfred P. Lutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred P. Lutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred P. Lutz more than expected).

Fields of papers citing papers by Manfred P. Lutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred P. Lutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred P. Lutz. The network helps show where Manfred P. Lutz may publish in the future.

Co-authorship network of co-authors of Manfred P. Lutz

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred P. Lutz. A scholar is included among the top collaborators of Manfred P. Lutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred P. Lutz. Manfred P. Lutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Percutaneous endoscopic colostomy to relieve malignant bowel obstruction 2024 ·European Journal of Case Reports in Internal Medicine ·(unknown), Markus Casper, Manfred P. Lutz	1
2	Advances in the management of hepatobiliary and pancreatic malignancies: highlights from the ESMO Annual Meeting 2023 by the EORTC GI Tract Cancer Group 2024 ·SHILAP Revista de lepidopterología ·Claudia Angela Maria Fulgenzi, Ingrid Garajová, Markus Moehler, Manfred P. Lutz, Elizabeth Smyth, Lorenza Rimassa, Cindy Neuzillet, Ángela Lamarca	1
3	Early Detection of Pancreatic Cancer 2023 ·Oncology Research and Treatment ·(unknown), (unknown), Lisa Schneider, (unknown), Manfred P. Lutz	2
4	Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group 2021 ·British Journal of Cancer ·Thibaud Koessler, María Alsina, Dirk Arnold, Irit Ben‐Aharon, Manfred P. Lutz, Radka Obermannová, Marc Peeters, Francesco Sclafani, Elizabeth Smyth, Juan W. Valle, Dorothea Wagner, Lucjan Wyrwicz, Elisa Fontana, Markus Moehler	3
5	LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study 2021 ·Annals of Oncology ·Thomas Seufferlein, Waldemar Uhl, Hana Algül, Helmut Frieß, Marko Kornmann, Alexander König, (unknown), Thomas M. Gress, Manfred P. Lutz, Kai Wille, Carl Christoph Schimanski, Volker Kunzmann, Andreas W. Berger, (unknown), Lukas Perkhofer, (unknown), Andrea Tannapfel, Margaret A. Tempero, Anke Reinacher‐Schick, Thomas J. Ettrich	5
6	Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071) 2018 ·Cancer Chemotherapy and Pharmacology ·(unknown), Markus Moehler, Arno Schad, Annett Maderer, Ajlan Atasoy, Murielle Mauer, Carmela Caballero, Thomas Thomaidis, Jestinah Mahachie John, István Láng, Eric Van Cutsem, (unknown), Manfred P. Lutz, Arnaud Roth	13
7	Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends 2018 ·Oncology Research and Treatment ·Phyllis F. Cheung, Manfred P. Lutz, Jens T. Siveke	8
8	Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983 2015 ·European Journal of Cancer ·E. Tanis, Catherine Julié, Jean‐François Emile, Murielle Mauer, Bernard Nordlinger, Daniela E. Aust, Arnaud Roth, Manfred P. Lutz, Thomas Gruenberger, Fritz Wrba, Halfdan Sørbye, Wolf O. Bechstein, P. Schlag, (unknown), Theo Ruers	56
9	O-018 Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC) 2015 ·Annals of Oncology ·Theo J. M. Ruers, C.J.A. Punt, Frits van Coevorden, Jean-Pierre E. N. Pierie, IHM Borel Rinkes, Jonathan A. Ledermann, Graeme J. Poston, Wolf O. Bechstein, M.A. Lentz, Murielle Mauer, E. Van Cutsem, Manfred P. Lutz, Bernard Nordlinger	29
10	Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin Vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Disease Free Survival at Interim Analysis 2014 ·Annals of Oncology ·Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price, Bernard Nordlinger, Ralf‐Dieter Hofheinz, Jean‐François Daisne, Jos Janssens, Baruch Brenner, (unknown), H. Reinel, S. Hollerbach, K Caca, F. Fauth, Carla Hannig, John Zalcberg, Niall C. Tebbutt, M. Mauer, Carlo Messina, Manfred P. Lutz, Eric Van Cutsem	6
11	Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Response to the Local Treatment After Chemoradiation and Surgery as Secondary Endpoint 2013 ·Annals of Oncology ·Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price, Bernard Nordlinger, Ralf‐Dieter Hofheinz, Jean‐François Daisne, Jos Janssens, Baruch Brenner, (unknown), H. Reinel, S. Hollerbach, K Caca, F. Fauth, Carla Hannig, John Zalcberg, Niall C. Tebbutt, Murielle Mauer, Carlo Messina, Manfred P. Lutz, Eric Van Cutsem	4
12	A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie 2010 ·Cancer Chemotherapy and Pharmacology ·(unknown), Markus Moehler, Manfred P. Lutz, Goetz von Wichert, (unknown), Jochen Klaus, Peter R. Galle, Guido Adler, Thomas Seufferlein	8
13	Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer 2007 ·PubMed ·Gunnar Folprecht, Claus-Henning Köhne, Manfred P. Lutz	34
14	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma 2005 ·Annals of Oncology ·Gunnar Folprecht, Manfred P. Lutz, Patrick Schöffski, Thomas Seufferlein, Arno Nolting, (unknown), C.-H. Köhne	192
15	Endoscopic Insertion of an M2A Video Capsule through an Overtube 2005 ·Endoscopy ·Wolfgang Mohl, A. Schneider, Manfred P. Lutz	4
16	The tyrosine kinase Yes regulates actin structure and secretion during pancreatic acinar cell damage in rats 2004 ·Pflügers Archiv - European Journal of Physiology ·(unknown), (unknown), (unknown), Michael Beil, Luis García, Manfred P. Lutz	29
17	Integrin ?6?1 role in metastatic behavior of human pancreatic carcinoma cells 1999 ·International Journal of Cancer ·Roger Vogelmann, (unknown), (unknown), Manfred P. Lutz	48
18	Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about it 1997 ·European Journal of Cancer ·Dietrich Rothenbacher, Manfred P. Lutz, Franz Porzsolt	122
19	G-CSF for Treatment Intensification in High-Grade Malignant Non-Hodgkin’s Lymphomas 1992 ·Oncology Research and Treatment ·B. Steinke, C. Manegold, Mathias Freund, H.-M. Reinold, J.-Th. Fischer, (unknown), Eva Lengfelder, Manfred P. Lutz, T. Zwingers, (unknown), T. Hecht	3
20	Large-scale cell separation by centrifugal elutriation 1992 ·Analytical Biochemistry ·Manfred P. Lutz, Gerhard Gaedicke, Wolfgang Hartmann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact